Ramsay Generale de Sante (GDS) AI Stock Analysis

• Market Cap: €1.18B
• Dividend Yield: N/A
• Average Volume (3M): 616.00
• Price to Earnings (P/E): ―
• Beta (1Y): 0.09
• Revenue Growth: 5.79%
• EPS Growth: -575.58%
• Country: FR
• Employees: 34,218
• Sector: Healthcare
• Sector Strength: 41
• Industry: Medical - Care Facilities
• EPS (TTM): -0.72
• Shares Outstanding: 110,389,690
• 10 Day Avg. Volume: 790
• 30 Day Avg. Volume: 616
• PEG Ratio: 2.28
• Price to Book (P/B): 0.95
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 2.43
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 58 Neutral
• Price Target: €10.50 ▼(-1.87%Downside)

Ramsay Generale de Sante faces challenges primarily from its financial performance, characterized by negative net income and high leverage. While there is some positive short-term technical momentum, valuation metrics are unattractive due to the negative earnings. The company must improve profitability and manage its debt to enhance its stock performance.

Ramsay Generale de Sante Business Overview & Revenue Model

Company Description

Ramsay Générale de Santé (GDS) is a leading private healthcare provider in France, operating a network of hospitals and clinics. The company offers a comprehensive range of medical services, including acute care, surgery, maternity care, oncology treatment, and rehabilitation. With a focus on delivering high-quality healthcare services, Ramsay Générale de Santé aims to meet the needs of patients across various medical specializations through its extensive network of healthcare facilities.

How the Company Makes Money

Ramsay Générale de Santé generates revenue primarily through patient services provided at its network of hospitals and clinics. The company earns money by billing for medical procedures, inpatient and outpatient care, and additional healthcare services such as diagnostic tests and consultations. Revenue streams are driven by reimbursements from public and private health insurance systems, as well as direct payments from patients. Additionally, strategic partnerships with healthcare professionals and collaborations with insurance providers and public health entities enhance its service offerings and contribute to its earnings.

Ramsay Generale de Sante Financial Statement Overview

Summary

Ramsay Generale de Sante shows a mixed financial picture. Revenue growth is positive, but profitability challenges are evident with a negative net income and declining margins. The balance sheet reveals high leverage, posing potential risks in liability management. Cash flow is a relative strength, providing some stability despite profit issues.

Income Statement

The income statement shows mixed performance. Revenue has grown steadily from $4.02B in 2021 to $5.14B TTM, with a recent growth rate of 2.74% compared to the previous annual period. However, net income has turned negative in the TTM period, indicating profitability challenges. EBIT and EBITDA margins have declined, reflecting operational inefficiencies or increased costs.

Balance Sheet

The balance sheet reveals high leverage with a debt-to-equity ratio of 3.48 in the TTM period, indicating significant reliance on borrowed funds. Stockholders' equity has decreased, and the equity ratio stands at 17.37%, suggesting limited equity buffer against liabilities. The return on equity has turned negative due to the net loss, highlighting concerns about current profitability.

Cash Flow

Cash flow analysis shows some strengths, with positive free cash flow of $440M in TTM and a 5.19% growth from the previous period. The operating cash flow to net income ratio is robust due to strong cash flow generation despite a net loss. However, the free cash flow to net income ratio highlights the pressure on profitability.

Breakdown
TTM	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Income Statement		Total Revenue
5.14B	5.01B	4.70B	4.30B	4.02B	3.75B
	Gross Profit
1.41B	3.94B	3.72B	3.41B	3.20B	3.01B
	EBIT
136.90M	184.20M	218.20M	281.10M	272.00M	184.70M
	EBITDA
535.50M	591.30M	656.30M	691.00M	604.00M	543.80M
	Net Income Common Stockholders
-79.70M	-53.90M	49.40M	118.40M	65.00M	18.70M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
157.80M	381.30M	362.90M	143.50M	620.00M	548.20M
	Total Assets
6.49B	6.90B	6.96B	6.79B	6.68B	6.71B
	Total Debt
3.92B	4.06B	4.15B	3.97B	3.85B	3.92B
	Net Debt
3.76B	3.70B	3.80B	3.83B	3.24B	3.38B
	Total Liabilities
5.33B	5.67B	5.68B	5.55B	5.58B	5.68B
	Stockholders Equity
1.13B	1.19B	1.25B	1.21B	1.07B	1.01B
Cash Flow		Free Cash Flow
440.00M	418.30M	426.70M	68.90M	475.90M	560.90M
	Operating Cash Flow
607.50M	586.80M	598.90M	262.50M	652.30M	729.60M
	Investing Cash Flow
-164.20M	-180.50M	-175.40M	-471.10M	-181.40M	-186.20M
	Financing Cash Flow
-470.30M	-401.50M	-197.10M	-264.20M	-390.60M	-377.20M

Ramsay Generale de Sante Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 10.70
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:GDS, the sentiment is Positive. The current price of 10.7 is above the 20-day moving average (MA) of 9.90, above the 50-day MA of 9.94, and below the 200-day MA of 11.78, indicating a neutral trend. The MACD of 0.14 indicates Negative momentum. The RSI at 67.94 is Neutral, neither overbought nor oversold. The STOCH value of 83.66 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FR:GDS.

Ramsay Generale de Sante Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SAN	76 Outperform	$112.16B	20.70	7.34%	3.91%	-4.62%	2.88%
VRLA	69 Neutral	€3.38B	13.95		7.68%	-11.47%	-49.98%
IPN	68 Neutral	€8.53B	24.48	8.89%	1.17%	8.73%	-46.34%
GDS	58 Neutral	€1.18B	―	-6.74%	―	5.79%	-575.58%
Sector *	53 Neutral	$5.18B	3.30	-45.04%	2.85%	16.82%	-0.65%